Oncternal Therapeutics Inc (ONCT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. James B. Breitmeyer
Employees:
13
12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
858 434-1113

Oncternal Therapeutics, Inc., formerly known as GTx, Inc.is a clinical-stage biotechnology company, develops various product candidates for the treatment of cancer.

Data derived from most recent annual or quarterly report
Market Cap 57.832 Million Shares Outstanding49.429 Million Avg 30-day Volume 2.461 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.28
Price to Revenue26.0032 Debt to Equity0.0 EBITDA-31.333 Million
Price to Book Value1.2733 Operating Margin-726.9060999999999 Enterprise Value21.439 Million
Current Ratio16.991 EPS Growth0.247 Quick Ratio16.608
1 Yr BETA 2.0417 52-week High/Low 5.27 / 0.69 Profit Margin-726.1414
Operating Cash Flow Growth-51.9806 Altman Z-Score7.8834 Free Cash Flow to Firm -21.497 Million
Earnings Report2022-08-04
View SEC Filings from ONCT instead.

View recent insider trading info

Funds Holding ONCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONCT BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-26:
    Item 8.01: Other Events
  • 8-K: filed on 2022-04-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
  • 8-K: filed on 2022-03-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-25:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2021-12-17:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-21:
    Item 1.02: Termination of a Material Definitive Agreement
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HALE DAVID F

    • Director
    37,500 2022-06-16 3

    KISNER DANIEL L

    • Director
    25,000 2022-06-16 1

    LARUE WILLIAM R

    • Director
    25,000 2022-06-16 1

    CARTER MICHAEL G

    • Director
    25,000 2022-06-16 1

    MAZANET ROSEMARY

    • Director
    25,000 2022-06-16 1

    THEUER CHARLES

    • Director
    25,000 2022-06-16 1

    WILLS ROBERT JAMES

    • Director
    25,000 2022-06-16 1

    NAKANISHI XIN

    • Director
    25,000 2022-06-16 1

    CHEN JINZHU PHD

    • Director
    25,000 2022-06-16 1

    VINCENT RICHARD G CHIEF FINANCIAL OFFICER

    • Officer
    177,687 2022-03-24 4

    BREITMEYER JAMES B CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    437,919 2022-01-27 3

    LEAVITT CHASE C. GENERAL COUNSEL/SECRETARY

    • Officer
    44,867 2022-01-27 3

    YAZJI SALIM CHIEF MEDICAL OFFICER

    • Officer
    67,137 2022-01-27 3

    KAUFMANN GUNNAR F. CHIEF SCIENTIFIC OFFICER

    • Officer
    162,457 2022-01-20 2

    KRISHNAN RAJESH CHIEF TECHNOLOGY OFFICER

    • Officer
    177,050 2022-01-20 2

    BILINSKY IGOR CHIEF BUSINESS OFFICER

    • Officer
    0 2021-02-11 0

    AKER HAZEL M LEGAL COUNSEL

    • Officer
    72,257 2020-07-21 0

    SHANGHAI PHARMACEUTICAL (USA) INC.

    SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.

    • 10% Owner
    4,069,089 2020-07-21 0

    SHANGHAI PHARMACEUTICALS (HK) INVESTMENT LTD

    • 10% Owner
    1,049,317 2020-07-21 0

    CHO MAN

    • Director
    0 2020-06-11 0

    HSU FRANK J. CHIEF MEDICAL OFFICER

    • Officer
    0 2020-03-17 0

    LIU YANJUN

    • Director
    0 2019-09-12 0

    SHANGHAI PHARMACEUTICAL (USA) INC.

    • 10% Owner
    0 2019-06-07 0

    HYDE JOSEPH R III

    • Director
    • 10% Owner
    6,877,615 2019-01-02 0

    NEIL GARRY ARTHUR

    • Director
    36,759 2019-01-02 0

    ROBINSON KENNETH S

    • Director
    44,105 2018-10-01 0

    YOUNG DIANE C. VP, CHIEF MEDICAL OFFICER

    • Officer
    45,936 2018-07-13 0

    DOGGRELL HENRY PATTON VP, CHIEF LEGAL OFFICER

    • Officer
    48,175 2018-06-20 0

    SHACKELFORD JASON T PRIN FIN. & ACCT. OFFICER

    • Officer
    19,548 2018-06-20 0

    GLASS J KENNETH

    • Director
    0 2018-05-10 0

    HANOVER MARC STEVEN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    172,049 2018-01-05 0

    PYRAMID PEAK FOUNDATION

    • 10% Owner
    4,729,417 2017-09-29 0

    FURR BARRY J. A.

    • Director
    48,469 2015-01-02 0

    DALTON JAMES T VP, CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2014-06-06 0

    SCHULER JACK W

    • 10% Owner
    6,165,261 2014-03-19 0

    STEINER MITCHELL SHUSTER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    4,673,367 2014-01-29 0

    MOSTELLER MARK EDWARD VICE PRESIDENT, CFO

    • Officer
    7,282 2013-07-08 0

    SEAR TIMOTHY R G

    • Director
    195,668 2013-01-01 0

    MORTON RONALD A JR VP, CHIEF MEDICAL OFFICER

    • Officer
    0 2012-01-01 0

    PONTIUS JOHN HOFMANN

    • Director
    157,339 2011-07-01 0

    DEENER GREGORY A VICE PRESIDENT

    • Officer
    0 2011-01-01 0

    KARR ROBERT W

    • Director
    0 2010-04-30 0

    BARNETTE K GARY VICE PRESIDENT

    • Officer
    No longer subject to file 2008-07-30 0

    HESSELBERG JEFFREY G VICE PRESIDENT, REGULATORY

    • Officer
    No longer subject to file 2008-07-30 0

    WEST CHRISTOPHER K VICE PRESIDENT - SALES

    • Officer
    No longer subject to file 2008-07-30 0

    BROWN MICHAEL DENNY VICE PRESIDENT

    • Officer
    No longer subject to file 2008-07-30 0

    DODSON SHONTELLE VICE PRESIDENT

    • Officer
    No longer subject to file 2008-07-30 0

    RODRIGUEZ DOMINGO VICE PRESIDENT

    • Officer
    No longer subject to file 2008-07-30 0

    CLARKSON ANDREW M

    • Director
    No longer subject to file 2008-06-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    LARUE WILLIAM R - Director

    2022-06-17 18:00:17 -0400 2022-06-16 A 25,000 a 25,000 direct

    THEUER CHARLES - Director

    2022-06-17 18:00:11 -0400 2022-06-16 A 25,000 a 25,000 direct

    HALE DAVID F - Director

    2022-06-17 18:01:18 -0400 2022-06-16 A 37,500 a 37,500 direct

    CARTER MICHAEL G - Director

    2022-06-17 18:00:58 -0400 2022-06-16 A 25,000 a 25,000 direct

    KISNER DANIEL L - Director

    2022-06-17 18:00:53 -0400 2022-06-16 A 25,000 a 25,000 direct

    MAZANET ROSEMARY - Director

    2022-06-17 18:00:48 -0400 2022-06-16 A 25,000 a 25,000 direct

    CHEN JINZHU PHD - Director

    2022-06-17 18:00:43 -0400 2022-06-16 A 25,000 a 25,000 direct

    NAKANISHI XIN - Director

    2022-06-17 18:00:32 -0400 2022-06-16 A 25,000 a 25,000 direct

    WILLS ROBERT JAMES - Director

    2022-06-17 18:00:25 -0400 2022-06-16 A 25,000 a 25,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 22:15:03 UTC 0.6523 0.9177 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 21:45:03 UTC 0.6523 0.9177 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 21:15:04 UTC 0.6523 0.9177 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 20:45:03 UTC 0.6054 0.9646 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 20:15:03 UTC 0.6054 0.9646 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 19:45:03 UTC 0.6054 0.9646 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 19:15:03 UTC 0.6054 0.9646 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 18:45:03 UTC 0.608 0.962 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 18:15:04 UTC 0.608 0.962 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 17:45:03 UTC 0.608 0.962 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 17:15:03 UTC 0.608 0.962 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 16:45:03 UTC 0.7294 0.8406 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 16:15:03 UTC 0.7294 0.8406 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 15:45:03 UTC 0.7294 0.8406 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 15:15:03 UTC 0.7294 0.8406 350000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 14:45:03 UTC 0.6995 0.8705 300000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 14:15:03 UTC 0.6995 0.8705 350000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 13:45:03 UTC 0.6995 0.8705 350000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 13:15:03 UTC 0.6995 0.8705 350000
    ONCTERNAL THERAPEUTICS INC ONCT 2022-06-24 12:45:03 UTC 0.6995 0.8705 350000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments